Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601830-24-000173
Filing Date
2024-10-04
Accepted
2024-10-04 18:30:19
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1728081013.html 4  
1 FORM 4 wk-form4_1728081013.xml 4 3194
  Complete submission text file 0001601830-24-000173.txt   4787
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O LUX CAPITAL MANAGEMENT, LLC 1600 EL CAMINO REAL - SUITE 290 MENLO PARK CA 94025
Business Address
Dar Zavain (Reporting) CIK: 0001852075 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 241355874